Genome Data Science lab

Excited to share our latest collaborative study of a frontier approach in cancer immunotherapy, targeting the Nonsense-Mediated mRNA Decay (NMD) pathway. Read more in a short 🧵+ link to preprint is below:

In this fascinating preprint, the authors uncover an eye-opening feature of tRNA genes: they’re insanely prone to mutation. Analyzing somatic mutations in cancer tissues, they report that tRNA genes are up to 9 times more mutated than protein-coding genes. Interestingly, the known biology of tRNA biology seems to line up neatly with this observation. tRNA genes are hypermutable for three reasons: - they are heavily transcribed than most protein-coding genes—more transcription means more chances for damage. - they’re transcribed by RNA Polymerase III, which lacks the robust DNA repair machinery that is coupled with RNA polymerase II that transcribe protein-coding genes. - they’re prime targets for APOBEC3 enzymes—viral defense agents that mutate single-stranded DNA and seem to hit tRNA genes as innocent bystanders. But the most interesting finding is this: when the somatic mutations hit the anticodon region (that recognizes amino-acid), they make the tRNAs to insert the wrong amino acids during translation, misspelling proteins without any change to the underlying DNA or mRNA. It's like a stealth mode mutation that defies the central dogma of biology, rewriting the proteome without touching the genome! Paper: Murillo-Recio et al. bioRxiv. Characterization of Somatic Mutations in Human tRNA Genes Reveals Tumor-Specific Mutational Loads, and the Generation of tRNA Variants that Alter the Genetic Code. bioRxiv 2025

Deadline for abstracts approaching! Don't miss this exciting DNA Replication Symposium 🧬 Stellar speaker lineup! MANY talks selected from abstracts.